SFX by Ex Libris Inc.

Title:	Molecular imaging in cancer
Source:	Science [0036-8075] Weissleder, R yr:2006

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Schlegel, W. "If you can't see it, you can miss it: the role of biomedical imaging in radiation oncology." Radiation protection dosimetry 139.1 (2010): 321-6.
description	2.	Morgan, B. "Opportunities and pitfalls of cancer imaging in clinical trials." Nature Reviews Clinical Oncology 8.9 (2011): 517-527.
description	3.	Mukhopadhyay, R. "Structural changes of DNA induced by mono- and binuclear cancer drugs." Journal of structural biology 150.3: 277-83.
description	4.	Montet, X. "Nanoparticle imaging of integrins on tumor cells." Neoplasia 8.3 (2006): 214-222.
description	5.	Benson, John D. "Validating cancer drug targets." Nature 441.7092 (2006): 451-456.
description	6.	Eich, HT. "Role of Radiological Imaging in Radiation Oncology: Experiences within the German Hodgkin Study Group (GHSG)." RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 185.S 01 (2013): 0033-33.
description	7.	Kaste, Sue C. "Oncological imaging: tumor surveillance in children." Pediatric radiology 41 Suppl 2.2 (2011): 505-508.
description	8.	Gomes, Clia M. "Molecular imaging with SPECT as a tool for drug development." Advanced drug delivery reviews 63.7 (2011): 547-554.
description	9.	Pandey, Kaushala N. "Radiobiological basis in management of accidental radiation exposure." International journal of radiation biology 86.8 (2010): 613-35.
description	10.	Montet, X. "Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas." Bioconjugate chemistry 17.4 (2006): 905-911.
description	11.	Reynolds, F. "Protamine as an efficient membrane-translocating peptide." Bioconjugate chemistry 16.5 (2005): 1240-1245.
description	12.	Bibby, David C. "Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice." International Journal of Pharmaceutics 293.1 (2005): 281-290.
description	13.	Shtatland, L. "Cell-specific targeting of nanoparticles by multivalent attachment of small molecules." Nature biotechnology 23.11 (2005): 1418-1423.
description	14.	Zardavas, D. "Emerging targeted agents in metastatic breast cancer." Nature Reviews Clinical Oncology 10.4 (2013): 191-210.
description	15.	Church, Dominique J. "Neuroscience in the courtroom: an international concern." William and Mary law review 53.5 (2012): 1825-1854.
description	16.	Heller, P. "Technoethics: The dilemma of doing the right moral thing in technology applications." International journal of technoethics 3.1 (2012): 14-27.
description	17.	Bains, Lauren J. "Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects." Magnetic resonance in medicine 64.2 (2010): 595-603.
description	18.	Laking, G R R. "Assessment of the technology for functional imaging in cancer." European journal of cancer 38.16 (2002): 2194-9.
description	19.	Avramovivic, M. "AFM studies of DNA structures extracted from adriamycin treated and non-treated Ehrlich tumor cells." Journal of the Serbian Chemical Society 70.6 (2005): 823-831.
description	20.	Sebolt-Leopold, Judith S S. "Mechanisms of drug inhibition of signalling molecules." Nature 441.7092 (2006): 457-62.